Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy.
Fatima AmorAi Vu HongGuillaume CorreMathilde SansonLaurence SuelStephanie BlaieLaurent ServaisThomas VoitIsabelle RichardDavid IsraeliPublished in: Journal of cachexia, sarcopenia and muscle (2021)
This investigation supports that cholesterol metabolism and the mevalonate pathway are potential therapeutic targets in DMD.